BioNexus Gene Lab Corp Common stock (BGLC) is a publicly traded Healthcare sector company. As of May 29, 2026, BGLC trades at $2.32 with a market cap of $5.80M and a P/E ratio of 0.00. BGLC moved -7.92% today. Year to date, BGLC is -39.24%; over the trailing twelve months it is -34.07%. Its 52-week range spans $1.92 to $15.60. Rallies surfaces BGLC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for BGLC combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.32 |
| Market Cap | $5.80M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.60 |
| 52-Week Low | $1.92 |
| Volume | 211.90K |
| Avg Volume | 0 |
| Revenue (TTM) | $7.42M |
| Net Income | $-2.98M |
| Gross Margin | 14.62% |
BGLC analyst coverage data. Average price target: $0.00.